Author:
Jesinghaus Moritz,Steiger Katja,Stögbauer Fabian,Haller Bernhard,Kolk Andreas,Straßen Ulrich,Pickhard Anja,Wirth Markus,Silva Miguel,Budczies Jan,Becker von Rose Aaron,Konukiewitz Björn,Kuhn Peer,Klinghammer Konrad,Dapper Hendrik,Münch Stefan,Combs Stephanie E.,Weichert Wilko,Boxberg Melanie
Abstract
Abstract
Background
Pre-operative treatment planning in head and neck squamous cell carcinoma (HNSCC) is mainly dictated by clinical staging, which has major shortcomings. Histologic grading is irrelevant due to its lack of prognostic impact. Recently, a novel grading termed Cellular Dissociation Grade (CDG) based on Tumour Budding and Cell Nest Size was shown to be highly prognostic for resected HNSCC. We aimed to probe the predictive and prognostic impact of CDG in the pre-operative biopsies of HNSCC.
Methods
We evaluated CDG in n = 160 pre-therapeutic biopsies from patients who received standardised treatment following German guidelines, and correlated the results with pre- and post-therapeutic staging data and clinical outcome.
Results
Pre-operative CDG was highly predictive of post-operative tumour stage, including the prediction of occult lymph node metastasis. Uni- and multivariate analysis revealed CDG to be an independent prognosticator of overall, disease-specific and disease-free survival (p < 0.001). Hazard ratio for disease-specific survival was 6.1 (11.1) for nG2 (nG3) compared with nG1 tumours.
Conclusions
CDG is a strong outcome predictor in the pre-treatment scenario of HNSCC and identifies patients with nodal-negative disease. CDG is a purely histology-based prognosticator in the pre-therapeutic setting that supplements clinical staging and may aide therapeutic stratification of HNSCC patients.
Funder
Else Kröner-Fresenius-Stiftung
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29 (2015).
2. Marur, S. & Forastiere, A. A. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 83, 489–501 (2008).
3. El-Naggar, A. K. (Hg.). WHO classification of head and neck tumours: International Agency for Research on Cancer. (2017).
4. Marur, S. & Forastiere, A. A. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 91, 386–396 (2016).
5. Pezzuto, F., Buonaguro, L., Caponigro, F., Ionna, F., Starita, N., Annunziata, C. et al. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology 89, 125–136 (2015).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献